1 From the Cardiology Branch, Section of Pathology and Clinic of Surgery, National Heart and Lung Institute, Bethesda, Maryland.
Previous studies have shown that abnormal cellular morphology is present in the ventricular septum of patients with asymmetric septal hypertrophy (ASH). The present study was undertaken to determine whether these morphologic abnormalities are limited to the ventricular septum of patients with ASH or are more diffusely distributed throughout the heart, and whether different patterns of distribution of the cellular abnormalities exist in patients with and patients without left ventricular outflow obstruction. Myocardium was obtained at operation or necropsy from 22 patients, including 14 with obstructive and eight with non-obstructive ASH, and studied by both light and electron microscopy. Many hypertrophied, bizarrely shaped, and abnormally arranged cardiac muscle cells, presumably a morphologic manifestation of the genetically transmitted myocardial defect in ASH, were present in the ventricular septum of all patients. In patients with obstructive ASH, these abnormalities were either absent or rarely found in muscle from the left and right ventricular free walls. This observation suggests that functional limitation in these patients is due largely to left ventricular outflow obstruction. In contrast, numerous disorganized cells were extensively distributed in the left and right ventricular feee walls from seven of eight symptomatic patients with non-obstructive ASH, suggesting that these abnormalities probably contribute importantly to functional impairment in such patients.
Submitted on November 1, 1973
© 1974 American Heart Association, Inc.
Differences in Distribution of Myocardial Abnormalities in Patients with Obstructive and Nonobstructive Asymmetric Septal Hypertrophy (ASH)
Light and Electron Microscopic Findings
Key Words: Ultrastructure Hypertrophic cardiomyopathy Idiopathic hypertrophic subaortic stenosis Ventricular hypertrophy Myocardium
Accepted on April 3, 1974
This article has been cited by other articles:
![]() |
H. Rakowski and S. Carasso Quantifying Diastolic Function in Hypertrophic Cardiomyopathy: The Ongoing Search for the Holy Grail Circulation, December 4, 2007; 116(23): 2662 - 2665. [Full Text] [PDF] |
||||
![]() |
A M Varnava, P M Elliott, S Sharma, W J McKenna, and M J Davies Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease Heart, November 1, 2000; 84(5): 476 - 482. [Abstract] [Full Text] |
||||
![]() |
T. Nakamura, H. Sugihara, N. Kinoshita, S. Yoneyama, A. Azuma, and M. Nakagawa Can Serum Carnitine Levels Distinguish Hypertrophic Cardiomyopathy From Hypertensive Hearts? Hypertension, August 1, 2000; 36(2): 215 - 219. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1974 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |